Aspiriant LLC’s MGIC Investment MTG Stock Holding History

Aspiriant LLC’s Portfolio MTG Stock Details MTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,000	Closed	-$112K	–	222
2016 Q4	$112K	Buy	+11,000	New	+$99.3K	0.01%	183

Other funds holding MTG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspiriant LLC's MTG Position: Q1 2017 in Review

Aspiriant LLC sold out of MGIC Investment (MTG) in Q1 2017, closing a stake of 11,000 shares — an estimated $112K sold.

Aspiriant LLC first reported a position in MTG in Q4 2016 and held it in 1 quarter. The position peaked at $112K in Q4 2016. 286 funds tracked by Wall St. Rank hold MTG as of Q1 2017.

Aspiriant LLC reported no remaining MGIC Investment position as of Q1 2017 after selling out during the quarter.
Aspiriant LLC sold 11,000 MGIC Investment shares in Q1 2017, an estimated $112K.
Aspiriant LLC first reported a position in MGIC Investment in Q4 2016 and held it in 1 quarter.
Aspiriant LLC's MGIC Investment position peaked at $112K in Q4 2016.
286 funds tracked by Wall St. Rank held MGIC Investment as of Q1 2017.

Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.